Incidence of household transmission of acute gastroenteritis (AGE) in a primary care sentinel network (1992-2017): cross-sectional and retrospective cohort study protocol by de Lusignan, Simon et al.
1de Lusignan S, et al. BMJ Open 2018;8:e022524. doi:10.1136/bmjopen-2018-022524
Open access 
Incidence of household transmission of 
acute gastroenteritis (AGE) in a primary 
care sentinel network (1992–2017): cross-
sectional and retrospective cohort 
study protocol
Simon de Lusignan,1,2 Emmanouela Konstantara,1 Mark Joy,1 Julian Sherlock,1 
Uy Hoang,1 Rachel Coyle,1 Filipa Ferreira,1 Simon Jones,1,3 Sarah J O’Brien4
To cite: de Lusignan S, 
Konstantara E, Joy M, et al.  
Incidence of household 
transmission of acute 
gastroenteritis (AGE) in a 
primary care sentinel network 
(1992–2017): cross-sectional 
and retrospective cohort 
study protocol. BMJ Open 
2018;8:e022524. doi:10.1136/
bmjopen-2018-022524
 ► Prepublication history and 
additional material for this 
paper are available online. To 
view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2018- 
022524). 
Received 22 February 2018
Revised 4 July 2018
Accepted 26 July 2018
For numbered affiliations see 
end of article.
Correspondence to
Professor Simon de Lusignan;  
 s. lusignan@ surrey. ac. uk
Protocol
© Author(s) (or their 
employer(s)) 2018. Re-use 
permitted under CC BY-NC. No 
commercial re-use. See rights 
and permissions. Published by 
BMJ.
AbstrACt
Introduction Acute gastroenteritis (AGE) is a highly 
transmissible condition. Determining characteristics 
of household transmission will facilitate development 
of prevention strategies and reduce the burden of this 
disease. We are carrying out this study to describe 
household transmission of medically attended AGE, 
and explore whether there is an increased incidence in 
households with young children.
Methods and analysis This study used the Royal 
College of General Practitioners (RCGP) Research and 
Surveillance Centre (RSC) primary care sentinel network, 
comprising data from 1 750 167 registered patients 
(August 2017 database). We conducted a novel analysis 
using a 'household key', to identify patients within the 
same household (n=811 027, mean 2.16 people). A 
25-year repeated cross-sectional study will explore the 
incidence of medically attended AGE overall and then a 
5-year retrospective cohort study will describe household 
transmission of AGE. The cross-sectional study will include 
clinical data for a 25-year period—1 January 1992 until 
the 31 December 2017. We will describe the incidence 
of AGE by age-band and gender, and trends in incidence. 
The 5-year study will use Poisson and quasi-Poisson 
regression to identify characteristics of individuals and 
households to predict medically attended AGE transmitted 
in the household. This will include whether the household 
contained a child under 5 years and the age category 
of the first index case (whether adult or child under 5 
years). If there is overdispersion and zero-inflation we will 
compare results with negative binomial to handle these 
issues.
Ethics and dissemination All RCGP RSC data are 
pseudonymised at the point of data extraction. No personally 
identifiable data are required for this investigation. 
The protocol follows STrengthening the Reporting of 
OBservational studies in Epidemiology guidelines (STROBE). 
The study results will be published in a peer-review journal, 
the dataset will be available to other researchers.
IntroduCtIon 
Acute gastroenteritis (AGE) contributes 
significantly to the burden of infectious 
diseases as well as having wider societal 
impact.1–9 It is estimated that around 25% 
of the population suffers from an AGE 
episode per year. However, in common with 
many other conditions general practitioners 
only see the tip of the epidemiological 
iceberg,10 11 with only 2% attending primary 
healthcare.1 2 AGE has direct healthcare costs 
from the disease itself as well as its complica-
tions; and indirect costs from the loss of days 
of work and other disruption caused by cases, 
clusters and outbreaks.12–15
The population groups most vulnerable 
to AGE are children under 5 years old16 and 
individuals with immunodeficiency17–20 and 
immunosuppression-related comorbidities.21 
WHO recommended rotavirus vaccination for 
infants,22–25 which was introduced in the UK 
in 201326–28 and has resulted in a significant 
strengths and limitations of this study
 ► UK general practice lends itself to this type of study 
because it is a registration base system (one patient 
registered with one general practitioner (GP)), and 
practices have been computerised since the 1990s.
 ► The Royal College of General Practitioners (RCGP) 
Research and Surveillance Centre (RSC) is one of 
the oldest sentinel networks in Europe, it recently 
celebrated its 50th Anniversary of collecting data 
about influenza and other infections in primary care, 
including acute gastroenteritis.
 ► RCGP RSC practices have had feedback about data 
quality including the importance of flagging first or 
new (incident) or review attendances.
 ► RCGP RSC data include a household key that en-
ables the pseudonymised records of individuals who 
live in the same household to be identified.
 ► Our data have limitations; we will underestimate 
household size if some residents in the same house-
hold are not registered with an RCGP RSC practice.
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decrease of AGE presentation in the target group as well 
as older individuals,29–31 suggesting herd immunity.32–35
AGE is a readily transmissible condition spreading 
rapidly between individuals and within institutions.12 13 36 
Like other infectious diseases, AGE requires a susceptible 
host and a favourable environment to spread. This can 
happen via direct person-to-person contact37 38 or an indi-
rect route (ie, contact with contaminated surfaces39 40). 
Young children (aged under 5 years) may be an important 
vector of this condition,36 41–43 as they have a twofold 
to eightfold greater risk than adults to acquire AGE44 
and are more likely to spread it to older children and 
adults.45–47 Determining the characteristics of household 
transmission will allow the development of appropriately 
targeted prevention strategies48 and ultimately reduce the 
burden on healthcare and society.
The mechanisms whereby household transmission may 
take place can be classified as transmission by food, water, 
animal or person-to-person. For example, Escherichia coli 
O157 has been transmitted from inadequately cooked 
beef, and in milk.49 Giardia intestinalis is a good example 
of protozoa principally acquired from contaminated 
water, but then passed by person-to person transmis-
sion.50 There is a reservoir of Salmonella in farm animals 
transmitted to humans via a range of foods, after which 
human-to-human transmission is important.51 Most 
viral gastroenteritis is transmitted by person-to-person 
spread or inhalation of droplets; this will be the the most 
common form of AGE, and most often lasts a few days and 
will not be reported to GPs.52
We are carrying out this study to describe the house-
hold transmission of medically attended AGE. Specif-
ically, whether adults who live in houses with children 
aged under 2 and 5 years have a higher incidence of AGE.
objectives
These are grouped by those that are derived from the 
repeated cross-sectional study and those from the retro-
spective cohort study.
Twenty-five-year repeated cross-sectional study:
 ► The rate of presentation with a first or new case of 
medically attended AGE per year.
 ► Individual characteristics which can predict presenta-
tion of AGE.
 ► The weekly incidence rates of medically attended 
AGE for children and adults.
Five-year retrospective cohort study:
 ► The primary outcome measure is the rate of pres-
entation of two or more individuals with medically 
attended AGE from the same household, within 10 
days. We will determine whether adults in households 
with young children (aged under 2 years and under 5 
years) have a higher incidence of medically attended 
AGE than those that do not.
 ► Household characteristics which can predict pres-
entation of medically attended AGE.
 ► The sequence of medically attended AGE presenta-
tion in the same household.
MEthods And AnAlysIs
study design
The study has two components, a repeated cross-sectional 
study and a retrospective cohort study. The repeated 
cross-section allows us to calculate the incidence of medi-
cally attended AGE and report trends in the population 
and incidence of medically attended AGE over time. The 
repeated cross-sectional analysis allows us to maximise the 
data available as the population registered at the start of 
our observation period will be different from that at the 
end. By way of comparison our retrospective cohort study 
will run for a shorter period and only include those regis-
tered with one of our network practices at the end of the 
study. The retrospective cohort study will explore house-
hold transmission rates.
We will conduct the 25-year repeated cross-sectional 
(1 January 1992 until 31 December 2017) and the 
5-year retrospective cohort study (1 January 2012 until 
31 December 2017) that will use the routinely collected 
primary care data within the RCGP RSC network data-
base. The rationale for our different time periods for the 
repeated cross-sectional and retrospective cohort studies 
is that while denominator and AGE incidence data are 
reliable for this longer period, our household key is only 
reliable for the last 5 years.
The August 2017 RCGP RSC database contained just 
under 1.8 million patients’ data, the 2002 database 
1 million and the 1992 database 350 000 (table 1). Each 
progressive extraction of RCGP RSC is larger as more 
practices join the network; we anticipate a larger number 
to be involved in this study.
study setting and population
We will carry out this study in the Royal College of General 
Practitioners (RCGP) Research and Surveillance Centre 
(RSC) primary care sentinel network. RCGP RSC lends 
itself to conducting this type of research.53 54 English 
general practice is a registration-based system, where indi-
viduals register with a single general practice and have a 
unique patient identifier (National Health Service (NHS) 
number).55 The network design allows people in the 
same household to be identified. Primary care records 
have been computerised since the 1990s. Key data are 
recorded using the Read terminology; this allows detailed 
coding of diagnosis, symptoms and other patient informa-
tion.56 Since 2004, most practices have been electronically 
linked to their local laboratory, ensuring all lab results 
are automatically posted into the practice computerised 
medical record (CMR) system; nearly all prescriptions are 
issued by GPs.
The RCGP RSC network database is a growing and 
nationally representative sentinel network. Based on 
the practices who were members in August 2017, it 
includes data from 175 general practices, 1 750 167 regis-
tered patients, amounting to approximately 3.1% of the 
National population.53 57 It is likely that a larger popula-
tion will be available for this study.
3de Lusignan S, et al. BMJ Open 2018;8:e022524. doi:10.1136/bmjopen-2018-022524
Open access
RCGP RSC is one of the oldest surveillance networks; it 
has been producing a weekly return on infectious disease, 
including gastroenteritis, for over 50 years.54 Over that 
period, practices have received feedback about their data 
quality, initially through practice visits, but more recently 
through online training and a practice dashboard.
The RCGP RSC is broadly representative of the national 
population in terms of: (1) age-sex distribution; (2) socio-
economic status, measured using the Index of Multiple 
Deprivation (IMD); (3) ethnicity58 59 and (4) urban-rural 
distribution, using the Office of National Statistics (ONS) 
classification.60 The population is slightly younger, more 
distributed towards London and urban locations, more 
ethnically mixed and less deprived—although these 
differences are small.53 The RCGP RSC actively recruits 
in areas where it is under-represented.
PAtIEnt And PublIC InvolvEMEnt
Patients were not involved in the development of this 
protocol.
household key
The RCGP RSC network database has a ‘household key,’ 
which can flag patients who live in the same household. 
This is assigned by flagging groups of individual with 
an identical first line or address and post code (this is 
done programmatically within the GP CMR system—
these personal data are not extracted). From the August 
2017 database, we identified 811 027 households with a 
mean size of 2.16 people. This compares with the 2011 
national census of 56 075 900 in 23 366 000 households 
and a mean size of 2.3657; 2.9% of the patients within 
the RSC did not have a household key assigned; this is 
largely because they do not have a properly formed post 
code.
The household key is defined as an identical first line 
of address and identical full post code. This matching is 
done programmatically, at the point of data extraction 
from the GP system so RCGP RSC staff do not have access 
to these data. We anticipate it is reliable because when a 
patient registers, the GP CMR system requires entry of 
the address once, and then assigns it to successive family 
members. However, it may underestimate true house-
hold size where one or more members of a household 
are registered with a different practice, which is not part 
of the RCGP RSC network. We class households of 12 or 
more as a ‘communal establishment’—and these groups 
are outside the scope of this study, in line with handling 
of data from ONS.61 Around a quarter of people live in 
two-person households (24.32), with a fifth each of living 
in single (22.34), three-person (19.08) or four-person 
(19.04) households (table 2).
AGE case definition
We will use the current RCGP RSC, ontologically devel-
oped case definition; which will be applied to all years 
of data analysed. An ontological approach to case defi-
nitions formally describes the concepts used to define 
the disease.62 A disease such as AGE can be defined by a 
combination of one or more concepts such as: diagnosis, 
clinical features, lab results and any treatment given.63 
Historically, RSC defined AGE using the diagnostic Read 
codes that mapped to equivalent infectious intestinal 
diseases codes within the International Classification of 
Disease (ICD).56 Our ontological approach was devel-
oped from the AGE definition used in the Second Study 
of Infectious Intestinal Disease in the Community,1 with 
the Read code mappings updated to match ICD-10.64 Our 
ontology can be readily mapped to other coding systems. 
For example, it will facilitate consistent case definition 
within the Systematised Nomenclature of Medicine—
Clinical Terms (SNOMED CT) when it is rolled out across 
the NHS in 2018.65 66
AGE incidence
Using RCGP RSC data (August 2017 extract), we have 
looked at the incidence of AGE over our 25-year study 
period. We have looked at the incidence by age band. We 
have used two modes, one separating off children under 
Table 1 RCGP RSC database size by year of database 
assembly
Extraction date Number of registered patients
31/08/2017 1 769 004
31/12/2016 1 750 168
31/12/2015 1 722 608
31/12/2014 1 689 412
31/12/2013 1 639 250
31/12/2012 1 588 022
31/12/2011 1 536 902
31/12/2010 1 493 611
31/12/2009 1 452 718
31/12/2008 1 414 621
31/12/2007 1 376 848
31/12/2006 1 337 105
31/12/2005 1 285 278
31/12/2004 1 237 254
31/12/2003 1 179 378
31/12/2002 1 034 446
31/12/2001 922 267
31/12/2000 820 163
31/12/1999 727 957
31/12/1998 648 774
31/12/1997 585 291
31/12/1996 523 976
31/12/1995 477 484
31/12/1994 431 264
31/12/1993 390 437
31/12/1992 343 484
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2 years (figure 1) and another separating off children 
under 5 years (figure 2).
The number of incident cases of AGE in the RCGP RSC 
in 2016 was 16 325; over the 15-year period of the retro-
spective cohort there are 297 691 cases, and over the last 
25 years 364 529 cases.
sample size calculation
We based our sample size on a proportion test on the 
two groups: households with an under 5 and households 
without an under 5.67 Since we are in the low prevalence 
rate regime, sample size of around 2650 enables us to 
detect an OR of around 2. Since we intend to extract a 
sample of a size much larger than 2650, we will be able to 
detect an OR of ≥2.1 with 80% power at the 5% level of 
significance.67 
outcome measures
Twenty-five-year repeated cross-sectional study:
 ► The rate of presentation with a first or new case of 
medically attended AGE per year.
 ► Individual characteristics that can predict presenta-
tion of medically attended AGE (box 1).
 ► The weekly incidence rates of medically attended 
AGE for children and adults.
Five-year retrospective study:
 ► The primary outcome measure is the rate of pres-
entation of two or more individuals with medically 
attended AGE from the same household, within 10 
days. We will determine whether adults in households 
with young children (aged under 2 years and under 5 
years) have a higher incidence of medically attended 
AGE than those that do not.
 ► Household characteristics that can predict presenta-
tion of medically attended AGE within households 
(box 2).
 ► The sequence of medically attended AGE presenta-
tion in the same household.
 ► Individual characteristics that can also predict pres-
entation of medically attended AGE within house-
holds (box 1).
Table 2 Household size in RCGP RSC
Household
size Female Male Population
Number of
households
Proportion of
population
Proportion of
households
1 181 422 189 754 371 176 371 176 22.34 46.25
2 212 256 191 772 404 028 202 014 24.32 25.17
3 163 992 152 916 316 908 105 636 19.08 13.16
4 158 282 158 010 316 292 79 073 19.04 9.85
5 69 385 71 170 140 555 28 111 8.46 3.50
>6 55 760 56 623 112 383 16 613 6.76 2.07
These data are from the August 2017 RCGP RSC extract and exclude households (communal establishments>12 people) and those without a 
valid post code, who do not have a household key.
RCGP RSC, Royal College of General Practitioners Research and Surveillance Centre. 
Figure 1 Incidence of gastroenteritis in Royal College of General Practitioners Research and Surveillance Centre 1992–2017, 
with children under 2 years in a separate age-band. IID, Infectious Intestinal Disease. 
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study variables and available data
For the cross-sectional study, we will extract age-band, 
gender and medically attended AGE data.
The retrospective cohort study will use the more 
extensive demographic and clinical data available in the 
database, as described above. We will additionally include 
the chronic diseases:
 ► Cardiovascular and cerebrovascular (heart disease, 
stroke, chronic kidney disease and hypertensions);
 ► Respiratory (asthma and chronic obstructive pulmo-
nary disease);
 ► Common mental health problems (anxiety and 
depression).
Figure 2 Incidence of gastroenteritis in Royal College of General Practitioners Research and Surveillance Centre 1992–2017, 
with children under 5 years in a separate age-band. IID, Infectious Intestinal Disease. 
box 1 Individual characteristics
Age
Gender
Ethnicity (2001 census)
 ► White
 ► Asian
 ► Black
 ► Mixed
 ► None
 ► Other
socioeconomic status (2001 census)
 ► IMD quintile 1—most deprived
 ► IMD quintile 2
 ► IMD quintile 3
 ► IMD quintile 4
 ► IMD quintile 5—least deprived
body mass index kg/m2 (2001 census)
 ► Underweight (<18.5)
 ► Normal (18.5–24.9)
 ► Overweight (25.0–29.9)
 ► Obese class 1 (30.0–34.9)
 ► Obese class 2 (35.0–39.9)
 ► Obese class 3 (≥40.0)
 ► None (information missing)
history of rotavirus vaccine
IMD, Index of Multiple Deprivation. 
box 2 household characteristics
Composition
Adults only (aged 18 years or more)
 ► 1–2 adults
 ► 3+ adults
Children aged under 5 years
 ► 1 child–1 adult
 ► 1 child–2+ adults
 ► 2+ children–1 adult
 ► 2+ children–2+ adults
Children aged over 5 years
 ► 1 child–1 adult
 ► 1 child–2+ adults
 ► 2+ children–1 adult
 ► 2+ children–2+ adults
Children of mixed ages and one adult
 ► 1 child <5 and 1+ >5–1 adult
 ► 2+ children <5 and 1+ >5–1 adult
 ► 1 child >5 and 1+ <5–2+ adults
 ► 2+ children >5 and 1+ <5–2+ adults
size
Mean (for census comparison) and median age
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statistical analysis
The cross-sectional study will use descriptive statistics to 
describe any trend in incidence over the 25-year observa-
tion period. We will also use descriptive statistics to deter-
mine both the standardised and crude rate for each year 
and to observe any individual characteristics in cases of 
medically attended AGE, such as ethnicity and body mass 
index.
The 5-year retrospective study will show incidence 
of two or more individuals from the same household 
presenting with medically attended AGE within 10 days 
of each other. Households will be grouped by whether 
they contain a child aged under  years or not. We will 
observe the intervals between presentations, as well as the 
sequence of occurrence for different age groups. We will 
explore Poisson and quasi-Poisson regression and we will 
address issues with overdispersion and zero-inflation by 
comparing results with negative binomial.
In order to determine representativeness of RCGP RSC 
household data, we will compare the mean size of house-
holds in our dataset with the 2011 census data mean from 
ONS48 using a one-sample t-test.
We do not plan a sensitivity analysis. We do not expect 
the low percentage of individuals with no valid household 
key recorded to have an effect on the study (n=1 750 167, 
out of which 50 979 patients without a household key 
recorded; 2.91%).
All statistical analysis will be performed using the statis-
tical package, RStudio, V.3.3.1.49 The R scripts will be 
available to readers on request.
usE of GuIdElInEs
This protocol was produced following the STrengthening 
the Reporting of OBservational studies in Epidemiology 
(STROBE) checklist for cohort studies (see online supple-
mentary file 1).
EthICAl ConsIdErAtIons
The study does not require formal ethics committee 
approval. All data to be used have been anonymised at 
the point of data extraction. The study has been reviewed 
by the University of Surrey Research Integrity and Gover-
nance Office, tested against the Health Research Authority 
(HRA)/Medical Research Council ‘is this research’ tool 
(http://www. hra- decisiontools. org. uk/ research/), and is 
considered to be an audit of current practice. No clin-
ically identifiable information will be made available to 
researchers or in any publications.
dIssEMInAtIon
The final agreed protocol and the outputs of this study 
will be published in a peer-reviewed open access journal 
within the domains of primary care, epidemiology, surveil-
lance, vaccines and infectious diseases. The research 
team will seek to present findings at relevant seminars 
and conferences.
A report with key findings, implication for practice and 
call for further research will be submitted to the funder at 
the end of the study. The data used for this research can 
be made available to other researchers on application to 
the corresponding author.
dIsCussIon
This is novel use of a household key within a primary 
care database to report if there is evidence of household 
transmission. This approach may be replicated to look for 
evidence of household transmission of other infections.
The RCGP RSC network database is appropriate for this 
research. RCGP RSC has records of over a quarter of a 
million cases of AGE, and good recording of its ‘house-
hold’ key. The limitation of these data are that we may 
under-record household size where one or more individ-
uals in a household are registered with a different prac-
tice. Additionally, we know that not all AGE is medically 
attended; it is possible that other cases of AGE may not be 
reported to a patient’s GP.
limitations of the study
Medically attended AGE
As described in the introduction, we are measuring trends 
in medially attended AGE and recognise this is a small 
proportion of the total incidence of this condition.10 11 
Household characteristics associated with AGE and the 
sequence of presentation in the household may reflect 
healthcare seeking behaviour, perception of risk as well 
as the dynamics of transmission.
Presentation with AGE at the time of presentation with other 
conditions
Some people attended about their comorbidity at the 
same time that they presented with AGE. We do not have 
data to know whether that management of their comor-
bidity was discussed at a time their presentation with AGE, 
or AGE mentioned at the time of presentation for their 
chronic disease. The proportion was greatest in those 
aged over 65 years, where 1.2%–5.6% presented on the 
same day with a comorbidity.
The household key underestimates the household size
If some residents in a household are registered with a 
practice outside the sentinel network, they would not 
be included in the household. We think this will happen 
less with families, and more with younger people and 
in conurbations where there is more choice of general 
practices.
Microbiological diagnoses are not commonly made in AGE in 
primary care
For a variety of reasons including that AGE is often 
self-limiting and there may be local limitations on testing, 
we anticipate finding few microbiologically proven cases. 
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Where they are recorded in the primary care computer-
ised medical record system, we will have access.
Some cases of AGE may go to the emergency department or 
hospital without attending primary care
We may not capture all more serious events, if they go 
straight to hospital. However, most practices record such 
data retrospectively into their primary care databases.
Notwithstanding these limitations, we anticipate 
reporting whether there is evidence of household spread 
of AGE using routine primary care data within the RCGP 
RSC database.
Author affiliations
1Department of Clinical and Experimental Medicine, University of Surrey, Guildford, 
UK
2Royal College of General Practitioners (RCGP) Research and Surveillance Centre 
(RSC), London, UK
3Center for Healthcare Innovation and Delivery Science, Department of Population 
Health, NYU School of Medicine, New York City, New York, USA
4NIHR Health Protection Research Unit in Gastrointestinal Infections, Liverpool, UK
Acknowledgements The authors would like to acknowledge the practices and 
patients of the Royal College of General Practitioners Research and Surveillance 
Centre (RCGP RSC), who allowed their pseudonymised clinical medical records 
to be used for this study. The authors would also like to thank Chris McGee, SQL 
developer, for his help with database management and data extraction.
Contributors SdeL conceived and designed the creation of a household key, the 
study, and led the writing of the manuscript. EK contributed to the manuscript. 
MJ contributed to the paper, and was lead medical statistician, including 
methodological and sample size advice. JS identified and processed all the baseline 
data and contributed to the manuscript. UH advised on study design and reviewed 
the manuscript. RC contributed to and reviewed the manuscript. FF contributed 
and reviewed the manuscript. SJ reviewed the statistical analysis design and the 
manuscript. SJOB reviewed the manuscript and study design and contributed to the 
final manuscript draft.
funding This research is funded by Takeda Pharmaceuticals. 
disclaimer The funders are updated periodically with the research; the funders 
have not had a role in the development of this protocol, and no access to the study 
dataset. 
Competing interests None declared.
Patient consent Not required.
Ethics approval Approval for this work has been granted by the RCGP RSC study 
approval committee. Although in accordance with their policy for studies that were 
not a result of competitive peer-reviewed award, they require an open access peer-
review protocol to be published. 
Provenance and peer review Not commissioned; externally peer reviewed.
data sharing statement RCGP RSC data are available to analyse. Application form 
online at www. rcgp. org. uk/ rsc. The authors will share their R scripts and the code 
lists used for this analysis.
open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the use 
is non-commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
rEfErEnCEs
 1. Tam CC, Viviani L, Rodrigues LC, et al. The second study of 
infectious intestinal disease (IID2): increased rates of recurrent 
diarrhoea in individuals aged 65 years and above. BMC Public Health 
2013;13:739.
 2. Tam CC, Rodrigues LC, Viviani L, et al. Longitudinal study of 
infectious intestinal disease in the UK (IID2 study): incidence in the 
community and presenting to general practice. Gut 2012;61:69–77.
 3. Dalby-Payne J, Elliott E. Gastroenteritis in children. BMJ Clin Evid 
2004;12:443–54.
 4. Black RE, Cousens S, Johnson HL, et al. Global, regional, and 
national causes of child mortality in 2008: a systematic analysis. 
Lancet 2010;375:1969–87.
 5. Wardlaw T, Salama P, Brocklehurst C, et al. Diarrhoea: why children 
are still dying and what can be done. Lancet 2010;375:870–2.
 6. Mokomane M, Kasvosve I, de Melo E, et al. The global problem of 
childhood diarrhoeal diseases: emerging strategies in prevention and 
management. Ther Adv Infect Dis 2018;5:29–43.
 7. Walker CLF, Rudan I, Liu L, et al. Global burden of childhood 
pneumonia and diarrhoea. Lancet 2013;381:1405–16.
 8. Fischer Walker CL, Perin J, Aryee MJ, et al. Diarrhea incidence in 
low- and middle-income countries in 1990 and 2010: a systematic 
review. BMC Public Health 2012;12:220.
 9. Liu L, Johnson HL, Cousens S, et al. Global, regional, and national 
causes of child mortality: an updated systematic analysis for 2010 
with time trends since 2000. Lancet 2012;379:2151–61.
 10. Last JM, Adelaide DP. The iceberg: 'completing the clinical picture' in 
general practice. 1963. Int J Epidemiol 2013;42:1608–13.
 11. Last JM. Commentary: the iceberg revisited. Int J Epidemiol 
2013;42:1613–5.
 12. Sandmann FG, Jit M, Robotham JV, et al. Burden, duration 
and costs of hospital bed closures due to acute gastroenteritis 
in England per winter, 2010/11-2015/16. J Hosp Infect 
2017;97:79–85.
 13. Lopman BA, Reacher MH, Vipond IB, et al. Epidemiology and cost of 
nosocomial gastroenteritis, Avon, England, 2002-2003. Emerg Infect 
Dis 2004;10:1827–34.
 14. Kirk MD, Pires SM, Black RE, et al. World health organization 
estimates of the global and regional disease burden of 22 foodborne 
bacterial, protozoal, and viral diseases, 2010: a data synthesis. PLoS 
Med 2015;12:e1001921.
 15. Kosek M, Bern C, Guerrant RL. The global burden of diarrhoeal 
disease, as estimated from studies published between 1992 and 
2000. Bull World Health Organ 2003;81:197–204.
 16. Giaquinto C, van Damme P. REVEAL Study Group. Age distribution 
of paediatric rotavirus gastroenteritis cases in Europe: the REVEAL 
study. Scand J Infect Dis 2010;42:142–7.
 17. Bok K, Green KY. Norovirus gastroenteritis in immunocompromised 
patients. N Engl J Med 2012;367:2126–32.
 18. Yin Y, Metselaar HJ, Sprengers D, et al. Rotavirus in organ 
transplantation: drug-virus-host interactions. Am J Transplant 
2015;15:585–93.
 19. Raini SK, Nyangao J, Kombich J, et al. Human rotavirus group a 
serotypes causing gastroenteritis in children less than 5 years and 
HIV-infected adults in Viwandani slum, Nairobi. Ethiop J Health Sci 
2015;25:39–46.
 20. Schwartz S, Vergoulidou M, Schreier E, et al. Norovirus 
gastroenteritis causes severe and lethal complications after 
chemotherapy and hematopoietic stem cell transplantation. Blood 
2011;117:5850–6.
 21. Vehreschild MJ, Vehreschild JJ, Hübel K, et al. Diagnosis and 
management of gastrointestinal complications in adult cancer 
patients: evidence-based guidelines of the Infectious Diseases 
Working Party (AGIHO) of the German Society of Hematology and 
Oncology (DGHO). Ann Oncol 2013;24:1189–202.
 22. Rotavirus vaccines. WHO position paper – January 2013. Wkly 
Epidemiol Rec 2013;88:49–64.
 23. Karafillakis E, Hassounah S, Atchison C. Effectiveness and impact of 
rotavirus vaccines in Europe, 2006-2014. Vaccine 2015;33:2097–107.
 24. Hungerford D, Read JM, Cooke RP, et al. Early impact of rotavirus 
vaccination in a large paediatric hospital in the UK. J Hosp Infect 
2016;93:117–20.
 25. World Health Organization. Meeting of the immunization 
strategic advisory group of experts, April 2009--conclusions and 
recommendations. Wkly Epidemiol Rec 2009;84:220–36.
 26. Public Health England. Rotavirus vaccination programme for 
infants. 2013 https://www. gov. uk/ government/ collections/ rotavirus- 
vaccination- progarmme- for- infants
 27. Soares-Weiser K, Maclehose H, Bergman H, et al. Vaccines for 
preventing rotavirus diarrhoea: vaccines in use. Cochrane Database 
Syst Rev 2012;11:Cd008521.
 28. Iturriza-Gómara M, Cunliffe N. Rotavirus vaccine: a welcome addition 
to the immunisation schedule in the UK. BMJ 2013;346:f2347.
 29. Marlow R, Muir P, Vipond B, et al. Assessing the impacts of the first 
year of rotavirus vaccination in the United Kingdom. Euro Surveill 
2015;20:30077.
8 de Lusignan S, et al. BMJ Open 2018;8:e022524. doi:10.1136/bmjopen-2018-022524
Open access 
 30. Atchison CJ, Stowe J, Andrews N, et al. Rapid declines in age 
group-specific rotavirus infection and acute gastroenteritis 
among vaccinated and unvaccinated individuals within 1 year of 
rotavirus vaccine introduction in England and Wales. J Infect Dis 
2016;213:243–9.
 31. Thomas SL, Walker JL, Fenty J, et al. Impact of the national rotavirus 
vaccination programme on acute gastroenteritis in England and 
associated costs averted. Vaccine 2017;35:680–6.
 32. Nakagomi O, Iturriza-Gomara M, Nakagomi T, et al. Incorporation of 
a rotavirus vaccine into the national immunisation schedule in the 
United Kingdom: a review. Expert Opin Biol Ther 2013;13:1613–21.
 33. Mughini-Gras L, Pijnacker R, Heusinkveld M, et al. Societal burden 
and correlates of acute gastroenteritis in families with preschool 
children. Sci Rep 2016;6:22144.
 34. Mast TC, Wang FT, Su S, et al. Evidence of herd immunity and 
sustained impact of rotavirus vaccination on the reduction 
of rotavirus-related medical encounters among infants from 
2006 through 2011 in the United States. Pediatr Infect Dis J 
2015;34:615–20.
 35. Pollard SL, Malpica-Llanos T, Friberg IK, et al. Estimating the herd 
immunity effect of rotavirus vaccine. Vaccine 2015;33:3795–800.
 36. Heusinkveld M, Mughini-Gras L, Pijnacker R, et al. Potential 
causative agents of acute gastroenteritis in households with 
preschool children: prevalence, risk factors, clinical relevance 
and household transmission. Eur J Clin Microbiol Infect Dis 
2016;35:1691–700.
 37. Karsten C, Baumgarte S, Friedrich AW, et al. Incidence and risk 
factors for community-acquired acute gastroenteritis in north-west 
Germany in 2004. Eur J Clin Microbiol Infect Dis 2009;28:935–43.
 38. Conrad D, Dee K, Keenan A, et al. The role of household 
transmission in an outbreak of viral gastroenteritis in a primary school 
in Liverpool, England. Public Health 2013;127:882–4.
 39. Repp KK, Hostetler TP, Keene WE. A norovirus outbreak related to 
contaminated surfaces. J Infect Dis 2013;208:295–8.
 40. Wikswo ME, Kambhampati A, Shioda K, et al. Outbreaks of 
acute gastroenteritis transmitted by person-to-person contact, 
environmental contamination, and unknown modes of transmission--
United States, 2009-2013. MMWR Surveill Summ 2015;64:1–16.
 41. Enserink R, Ypma R, Donker GA, et al. Infectious disease burden 
related to child day care in the Netherlands. Pediatr Infect Dis J 
2013;32:1–40.
 42. Phillips G, Tam CC, Rodrigues LC, et al. Risk factors for symptomatic 
and asymptomatic norovirus infection in the community. Epidemiol 
Infect 2011;139:1676–86.
 43. Götz H, Ekdahl K, Lindbäck J, et al. Clinical spectrum and 
transmission characteristics of infection with Norwalk-like virus: 
findings from a large community outbreak in Sweden. Clin Infect Dis 
2001;33:622–8.
 44. Perry S, de la Luz Sanchez M, Hurst PK, et al. Household 
transmission of gastroenteritis. Emerg Infect Dis 2005;11:1093–6.
 45. Chapin AR, Carpenter CM, Dudley WC, et al. Prevalence of norovirus 
among visitors from the United States to Mexico and Guatemala who 
experience traveler's diarrhea. J Clin Microbiol 2005;43:1112–7.
 46. Simmons K, Gambhir M, Leon J, et al. Duration of immunity to 
norovirus gastroenteritis. Emerg Infect Dis 2013;19:1260–7.
 47. Sacri AS, De Serres G, Quach C, et al. Transmission of acute 
gastroenteritis and respiratory illness from children to parents. 
Pediatr Infect Dis J 2014;33:583–8.
 48. Lopman B. Global burden of norovirus and prospects for vaccine 
development: CDC Found, 2015.
 49. Adams NL, Byrne L, Smith GA, et al. Shiga toxin-producing 
escherichia coli O157, England and Wales, 1983-2012. Emerg Infect 
Dis 2016;22:590–7.
 50. Casemore DP. Foodborne protozoal infection. Lancet 
1990;336:1427–32.
 51. World Health Organisation. Salmonella (non-typhoidal). 2018 http://
www. who. int/ news- room/ fact- sheets/ detail/ salmonella-(non-
typhoidal)
 52. Seymour IJ, Appleton H. Foodborne viruses and fresh produce. J 
Appl Microbiol 2001;91:759–73.
 53. Correa A, Hinton W, McGovern A, et al. Royal College of General 
Practitioners Research and Surveillance Centre (RCGP RSC) sentinel 
network: a cohort profile. BMJ Open 2016;6:e011092.
 54. de Lusignan S, Correa A, Smith GE, et al. RCGP research and 
surveillance centre: 50 years' surveillance of influenza, infections, 
and respiratory conditions. Br J Gen Pract 2017;67:440–1.
 55. NHS Digital. NHS number. https:// digital. nhs. uk/ services/ nhs- number
 56. de Lusignan S. Codes, classifications, terminologies and 
nomenclatures: definition, development and application in practice. 
Inform Prim Care 2005;13:65–9.
 57. Office for National Statistics. 2011 census: population and household 
estimates for the United Kingdom, March 2011. 2011 https://www. 
ons. gov. uk/ peop lepo pula tion andc ommunity/ popu lati onan dmig ration/ 
populationestimates/ bulletins/ 2011 cens uspo pula tion andh ouse hold 
esti mate sfor engl anda ndwales/ 2012- 07- 16
 58. Kumarapeli P, Stepaniuk R, de Lusignan S, et al. Ethnicity 
recording in general practice computer systems. J Public Health 
2006;28:283–7.
 59. Tippu Z, Correa A, Liyanage H, et al. Ethnicity recording in primary 
care computerised medical record systems: an ontological approach. 
J Innov Health Inform 2017;23:799.
 60. Office for National Statistics. 2011 rural/urban classification. 
2011 https://www. ons. gov. uk/ methodology/ geography/ 
geographicalproducts/ rura lurb ancl assi fica tions/ 2011 rura lurb ancl assi 
fication
 61. Office for National Statistics. Occupied address (household) 
estimates from Administrative Data: 2011 and 2015. 2015 https://
www. ons. gov. uk/ census/ cens ustr ansf orma tion prog ramme/ admi nist 
rati veda tace nsus project/ admi nist rati veda tace nsus rese arch outputs/ 
hous ehol dsan dfam ilies/ occu pied addr essh ouse hold esti mate sfro 
madm inis trat ived ata2 011a nd2015
 62. de Lusignan S. In this issue: Ontologies a key concept in informatics 
and key for open definitions of cases, exposures, and outcome 
measures. J Innov Health Inform 2015;22:170.
 63. Liu L, Özsu MT. Encyclopedia of database systems. Heidelberg, 
Germany: Springer Berlin, 2009.
 64. de Lusignan S, Shinneman S, Yonova I, et al. An ontology to 
improve transparency in case definition and increase case finding 
of infectious intestinal disease: database study in english general 
practice. JMIR Med Inform 2017;5:e34.
 65. de Lusignan S, Chan T, Jones S. Large complex terminologies: more 
coding choice, but harder to find data--reflections on introduction 
of SNOMED CT (Systematized Nomenclature of Medicine--Clinical 
Terms) as an NHS standard. Inform Prim Care 2011;19:3–5.
 66. NHS Digital. SNOMED CT implementation in primary care. https:// 
digital. nhs. uk/ services/ terminology- and- classifications/ snomed- ct/ 
snomed- ct- implementation- in- primary- care
 67. Hsieh FY, Bloch DA, Larsen MD. A simple method of sample 
size calculation for linear and logistic regression. Stat Med 
1998;17:1623–34.
